MX9303158A - Derivados de aminoquinolona substituidos con grupoarilo o con un grupo heterociclico aromatico; y agente anti-vih. - Google Patents
Derivados de aminoquinolona substituidos con grupoarilo o con un grupo heterociclico aromatico; y agente anti-vih.Info
- Publication number
- MX9303158A MX9303158A MX9303158A MX9303158A MX9303158A MX 9303158 A MX9303158 A MX 9303158A MX 9303158 A MX9303158 A MX 9303158A MX 9303158 A MX9303158 A MX 9303158A MX 9303158 A MX9303158 A MX 9303158A
- Authority
- MX
- Mexico
- Prior art keywords
- aminoquinolone
- grupoarilo
- hetero
- aromatic group
- derivatives substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/06—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Chemical & Material Sciences (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Se describe un compuesto de aminoquinolona, substituido con un grupo arilo o con un grupo heterocíclico, representado por la fórmula (Ia), (Ib) o (Ic), en donde cada uno de los sustituyentes se define en la memoria descriptiva: o una sal del compuesto; y un agente para curar el SIDA, que lo contiene como ingrediente efectivo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15891292 | 1992-05-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9303158A true MX9303158A (es) | 1994-04-29 |
Family
ID=15682065
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9303158A MX9303158A (es) | 1992-05-27 | 1993-05-27 | Derivados de aminoquinolona substituidos con grupoarilo o con un grupo heterociclico aromatico; y agente anti-vih. |
Country Status (18)
Country | Link |
---|---|
US (2) | US5519016A (es) |
EP (1) | EP0572259A1 (es) |
KR (1) | KR100266305B1 (es) |
CN (1) | CN1042936C (es) |
AU (1) | AU656859B2 (es) |
CA (1) | CA2096998A1 (es) |
CZ (1) | CZ99693A3 (es) |
FI (1) | FI932412A (es) |
HU (1) | HUT64051A (es) |
ID (1) | ID20476A (es) |
IL (1) | IL105806A (es) |
MX (1) | MX9303158A (es) |
NO (1) | NO304832B1 (es) |
NZ (1) | NZ247720A (es) |
PH (1) | PH31078A (es) |
RU (1) | RU2124510C1 (es) |
TW (1) | TW234121B (es) |
ZA (1) | ZA933732B (es) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4329600A1 (de) * | 1993-09-02 | 1995-03-09 | Bayer Ag | Pyrido [1,2,3-d,e] [1,3,4] benzoxadiazinderivate |
WO1996002512A1 (fr) * | 1994-07-18 | 1996-02-01 | Ube Industries, Ltd. | Acide du type trifluoromethylquinoleinecarboxylique |
DE4425649A1 (de) * | 1994-07-20 | 1996-01-25 | Bayer Ag | Neue 1-[4-(Aminomethyl)phenyl] substituierte Chinoloncarbonsäuren |
DE4425647A1 (de) * | 1994-07-20 | 1996-01-25 | Bayer Ag | Heterocyclyl-1-phenyl substituierte Chinoloncarbonsäuren |
DE4425660A1 (de) * | 1994-07-20 | 1996-01-25 | Bayer Ag | 7-substituierte 1-[4-(1H-1,2,4-triazol-1-yl-methyl)phenyl] substituierte Chinoloncarbonsäuren |
PT793656E (pt) * | 1994-11-24 | 2003-07-31 | Basilea Pharmaceutica Ag | Novas benzil-pirimidinas |
US5620997A (en) * | 1995-05-31 | 1997-04-15 | Warner-Lambert Company | Isothiazolones |
PT992501E (pt) * | 1995-09-22 | 2003-01-31 | Wakunaga Pharma Co Ltd | Derivados de acido piridonacarboxilico como agentes antibacterianos |
US6001863A (en) * | 1996-11-26 | 1999-12-14 | Warner-Lambert Company | Isothiazolones |
US6387928B1 (en) | 1997-09-15 | 2002-05-14 | The Procter & Gamble Co. | Antimicrobial quinolones, their compositions and uses |
HUP0100051A3 (en) | 1997-09-15 | 2002-08-28 | Procter & Gamble | Antimicrobial quinolones, their compositions and uses |
DE19751948A1 (de) * | 1997-11-24 | 1999-05-27 | Bayer Ag | Verfahren zur Herstellung von 8-Methoxy-Chinoloncarbonsäuren |
IL124195A (en) * | 1998-04-23 | 2000-08-31 | Chemagis Ltd | Process for the preparation of esters of 2-¬4-¬4-chlorophenyl¾phenylmethyl¾-1-piperazinyl¬ethoxy¾acetic acid |
DE69931974D1 (de) * | 1998-08-12 | 2006-07-27 | Ihara Chemical Ind Co | N-Cyclopropyl-2-difluormethoxy-3-bromanilin und ein Zwischenprodukt zu seiner Herstellung |
ES2216606T3 (es) * | 1998-12-21 | 2004-10-16 | Aventis Pharma S.A. | Derivados de la benzo-1,8-naftiridina. |
MXPA02007667A (es) * | 2000-02-09 | 2003-04-14 | Daiichi Seiyaku Co | Agentes antibacterianos antiacidos-resistentes que contienen acidos piridoncarboxilicos como el ingrediente activo. |
US6514529B2 (en) | 2000-03-22 | 2003-02-04 | Pharmacia & Upjohn Company | Oxazolidinone tablet formulation |
MY127336A (en) | 2000-03-22 | 2006-11-30 | Upjohn Co | Container for linezolid iv solution |
US6608078B2 (en) | 2000-05-08 | 2003-08-19 | Wockhardt Limited | Antibacterial chiral 8-(substituted piperidino)-benzo [i,j] quinolizines, processes, compositions and methods of treatment |
US7098219B2 (en) | 2000-08-01 | 2006-08-29 | Wockhart Limited | Inhibitors of cellular efflux pumps of microbes |
AR031135A1 (es) | 2000-10-10 | 2003-09-10 | Upjohn Co | Composiciones de antibiotico topico para el tratamiento de infecciones oculares |
PL363301A1 (en) | 2000-12-14 | 2004-11-15 | The Procter & Gamble Company | Antimicrobial 2-pyridones, their compositions and uses |
WO2002048138A1 (en) | 2000-12-14 | 2002-06-20 | The Procter & Gamble Company | Antimicrobial quinolones |
US6964966B2 (en) | 2001-04-25 | 2005-11-15 | Wockhardt Limited | Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments |
US6878713B2 (en) | 2001-04-25 | 2005-04-12 | Wockhardt Limited | Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments |
AU2003213210A1 (en) * | 2002-02-22 | 2003-09-09 | Pharmacia Corporation | Ophthalmic formulation with gum system |
BR0307898A (pt) * | 2002-02-22 | 2004-12-07 | Pharmacia Corp | Formulações de droga antibiótica oftálmica contendo um composto de ciclodextrina e cloreto de cetil piridìnio |
WO2003099815A1 (en) | 2002-05-28 | 2003-12-04 | Wockhardt Limited | Crystalline fluoroquinolone arginine salt form |
EP1564210B9 (en) * | 2002-11-20 | 2010-03-31 | Japan Tobacco Inc. | 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors |
TW200510425A (en) * | 2003-08-13 | 2005-03-16 | Japan Tobacco Inc | Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor |
US7164023B2 (en) | 2003-09-04 | 2007-01-16 | Wockhardt Limited | Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate |
ES2232309B1 (es) * | 2003-11-13 | 2006-08-01 | Quimica Sintetica, S.A. | Procedimiento simplificado para la obtencion de gatifloxacino. |
ATE482208T1 (de) * | 2004-03-10 | 2010-10-15 | Us Of America Represented By T | Chinolin-4-one als inhibitoren der retroviralen integrase zur behandlung von hiv, aids und aids- related complex (arc) |
MY134672A (en) * | 2004-05-20 | 2007-12-31 | Japan Tobacco Inc | Stable crystal of 4-oxoquinoline compound |
US7531554B2 (en) * | 2004-05-20 | 2009-05-12 | Japan Tobacco Inc. | 4-oxoquinoline compound and use thereof as HIV integrase inhibitor |
KR100589429B1 (ko) | 2004-08-31 | 2006-06-14 | 한국화학연구원 | N-1 위치에 아미노피리딜기가 치환된 퀴놀론 유도체의 제조방법 |
US7732612B2 (en) * | 2004-09-09 | 2010-06-08 | Janssen Pharmaceutica, N.V. | 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
US20090156577A1 (en) * | 2004-09-09 | 2009-06-18 | Benjamin Davis | 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
JP2008519842A (ja) * | 2004-11-11 | 2008-06-12 | アキリオン ファーマシューティカルズ,インコーポレーテッド | 抗感染剤としての8a,9−ジヒドロ−4a−h−イソチアゾロ[5,4−b]キノリン−3,4−ジオンおよび関連化合物 |
US7659399B2 (en) * | 2005-01-05 | 2010-02-09 | Achillion Pharmaceuticals, Inc. | 1-thia-2,4a-diaza-cyclopenta[b]napththalene-3,4-diones and related compounds as anti-infective agents |
WO2006084053A1 (en) * | 2005-02-02 | 2006-08-10 | Achillion Pharmaceuticals, Inc. | 8-n-substituted-2h-isothiazolo[5,4-b]quinolizine-3,4-diones and related compounds as antiinfective agents |
EA200701734A1 (ru) * | 2005-02-16 | 2008-02-28 | Ачиллион Фармасьютикалз, Инк. | Новые изотиазолохинолоны и родственные им соединения как антиинфекционные средства |
CA2616768C (en) * | 2005-07-27 | 2014-05-06 | Achillion Pharmaceuticals, Inc. | 8-methoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents |
KR101023635B1 (ko) * | 2006-03-06 | 2011-03-22 | 니뽄 다바코 산교 가부시키가이샤 | 4-옥소퀴놀린 화합물 제조 방법 |
CN101045724B (zh) * | 2006-03-28 | 2011-08-17 | 宝洁公司 | 用于制备喹诺酮中间体的偶联方法 |
MX2008012328A (es) | 2006-03-28 | 2008-10-09 | Procter & Gamble | Sales de malato, y polimorfos de acido (3s,5s)-7-[3-amino-5-metil- piperidinil]-1-ciclopropil-1,4-dihidro-8-metoxi-4-oxo-3-quinolinc arboxilico. |
KR101084521B1 (ko) | 2006-03-28 | 2011-11-18 | 워너 칠콧 컴퍼니 엘엘씨 | 퀴놀론 중간체를 제조하기 위한 커플링 방법 |
CA2647457C (en) * | 2006-03-28 | 2011-05-24 | The Procter & Gamble Company | A hydride reduction process for preparing quinolone intermediates |
US20080318939A1 (en) * | 2007-06-22 | 2008-12-25 | Whitten Jeffrey P | Methods for treating ophthalmic disorders |
CN101801190A (zh) * | 2007-06-22 | 2010-08-11 | 赛林药物股份有限公司 | 治疗异常细胞增殖性疾病的方法 |
US7902227B2 (en) * | 2007-07-27 | 2011-03-08 | Janssen Pharmaceutica Nv. | C-7 isoxazolinyl quinolone / naphthyridine derivatives useful as antibacterial agents |
AU2008299903B2 (en) * | 2007-09-11 | 2013-08-29 | Kyorin Pharmaceutical Co., Ltd | Cyanoaminoquinolones and tetrazoloaminoquinolones as GSK-3 inhibitors |
US8476261B2 (en) | 2007-09-12 | 2013-07-02 | Kyorin Pharmaceutical Co., Ltd. | Spirocyclic aminoquinolones as GSK-3 inhibitors |
EP2209380A4 (en) * | 2007-10-09 | 2011-09-14 | Mark T Hamann | METHOD OF USE OF COMPOSITIONS WITH ANTIDEPRESSIVE EFFICACY, MOOD EFFICACY AND OTHER NEUROLOGICAL EFFECTIVENESS AND COMPOSITIONS THEREOF |
EP2222662A4 (en) * | 2007-11-15 | 2011-08-03 | Univ Maryland | INHIBITORS OF KYNURENINE AMINO TRANSFERASE |
US20110166123A1 (en) * | 2008-01-07 | 2011-07-07 | Aardea Biosciences, Inc. | Novel compositions and methods of use |
CN102388053A (zh) * | 2009-04-03 | 2012-03-21 | 艾其林医药公司 | 作为抗感染剂的羟基噻吩并喹诺酮类及相关化合物 |
EA201101564A1 (ru) | 2009-05-15 | 2012-07-30 | Редкс Фарма Лимитед | Редокс производные лекарственных средств |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5097032A (en) * | 1984-07-20 | 1992-03-17 | Warner-Lambert Company | Antibacterial agents - II |
US5210193A (en) * | 1986-01-17 | 1993-05-11 | American Cyanamid Company | Piperazine derivatives |
US4840956A (en) * | 1986-02-18 | 1989-06-20 | Warner-Lambert Company | Novel disubstituted-7-pyrrolidinoquinoline antibacterial agents |
DE3705621C2 (de) * | 1986-02-25 | 1997-01-09 | Otsuka Pharma Co Ltd | Heterocyclisch substituierte Chinoloncarbonsäurederivate |
IT1197841B (it) * | 1986-10-14 | 1988-12-06 | Mediolanum Farmaceutici Srl | Derivati pirido-benzotiazinici ad attivita' antibatterica ed a lunga durata di azione |
JPH0751579B2 (ja) * | 1987-11-07 | 1995-06-05 | 日本新薬株式会社 | キノリンカルボン酸誘導体 |
WO1990013542A1 (fr) * | 1989-04-28 | 1990-11-15 | Daiichi Pharmaceutical Co., Ltd. | Medicament anti-hiv |
DE3934082A1 (de) * | 1989-10-12 | 1991-04-18 | Bayer Ag | Chinoloncarbonsaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung als antivirale mittel |
JPH0754830Y2 (ja) * | 1990-01-24 | 1995-12-18 | 株式会社ユニシアジェックス | 荷重センサ取付構造 |
KR920004385A (ko) * | 1990-08-09 | 1992-03-27 | 와꾸나가 기스께 | 신규 삼환화합물 또는 그의 염, 이의 제조방법 및 이를 함유하는 항균제 |
WO1992021659A1 (en) * | 1991-05-28 | 1992-12-10 | Daiichi Pharmaceutical Co., Ltd. | Pyridonecarboxylic acid derivative |
-
1993
- 1993-05-24 NO NO931867A patent/NO304832B1/no not_active IP Right Cessation
- 1993-05-25 IL IL105806A patent/IL105806A/en not_active IP Right Cessation
- 1993-05-26 PH PH46240A patent/PH31078A/en unknown
- 1993-05-26 TW TW082104157A patent/TW234121B/zh active
- 1993-05-26 HU HU9301536A patent/HUT64051A/hu unknown
- 1993-05-26 CA CA002096998A patent/CA2096998A1/en not_active Abandoned
- 1993-05-26 RU RU93035829A patent/RU2124510C1/ru active
- 1993-05-26 FI FI932412A patent/FI932412A/fi unknown
- 1993-05-26 CZ CZ93996A patent/CZ99693A3/cs unknown
- 1993-05-26 AU AU39815/93A patent/AU656859B2/en not_active Ceased
- 1993-05-27 ZA ZA933732A patent/ZA933732B/xx unknown
- 1993-05-27 EP EP93304139A patent/EP0572259A1/en not_active Ceased
- 1993-05-27 KR KR1019930009397A patent/KR100266305B1/ko not_active IP Right Cessation
- 1993-05-27 MX MX9303158A patent/MX9303158A/es not_active IP Right Cessation
- 1993-05-27 NZ NZ247720A patent/NZ247720A/en unknown
- 1993-05-27 CN CN93108210A patent/CN1042936C/zh not_active Expired - Fee Related
- 1993-05-27 ID IDP98154193A patent/ID20476A/id unknown
-
1994
- 1994-11-15 US US08/341,295 patent/US5519016A/en not_active Expired - Fee Related
-
1995
- 1995-09-11 US US08/526,225 patent/US5688791A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
RU2124510C1 (ru) | 1999-01-10 |
HU9301536D0 (en) | 1993-09-28 |
KR100266305B1 (ko) | 2000-09-15 |
US5688791A (en) | 1997-11-18 |
TW234121B (es) | 1994-11-11 |
AU3981593A (en) | 1993-12-02 |
KR930023360A (ko) | 1993-12-18 |
NZ247720A (en) | 1994-09-27 |
AU656859B2 (en) | 1995-02-16 |
PH31078A (en) | 1998-02-05 |
NO931867D0 (no) | 1993-05-24 |
NO304832B1 (no) | 1999-02-22 |
US5519016A (en) | 1996-05-21 |
IL105806A0 (en) | 1993-09-22 |
CN1086515A (zh) | 1994-05-11 |
NO931867L (no) | 1993-11-29 |
CA2096998A1 (en) | 1993-11-28 |
FI932412A (fi) | 1993-11-28 |
EP0572259A1 (en) | 1993-12-01 |
ZA933732B (en) | 1993-12-15 |
CZ99693A3 (en) | 1993-12-15 |
FI932412A0 (fi) | 1993-05-26 |
ID20476A (id) | 1998-12-24 |
IL105806A (en) | 1998-02-22 |
HUT64051A (en) | 1993-11-29 |
CN1042936C (zh) | 1999-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9303158A (es) | Derivados de aminoquinolona substituidos con grupoarilo o con un grupo heterociclico aromatico; y agente anti-vih. | |
AR247585A1 (es) | Una solucion para el tratamiento de metales y el procedimiento para llevarlo a cabo | |
ATE6422T1 (de) | 3-aryloxy-3-phenylpropylamine. | |
ES2032899T3 (es) | Agente cosmetico para aplicacion externa y su uso. | |
ES2097872T3 (es) | Fenilpirazolidinonas como agentes broncodilatadores y antiinflamatorios. | |
ES2175161T3 (es) | Derivados de piperazina como antagonistas de taquiquinina. | |
MX9303597A (es) | Derivados de imidazopirinas, procedimiento para su preparacion preparaciones farmaceuticas que los contienen. | |
FI865233A0 (fi) | Pyrazolinderivat, deras framstaellning och anvaendning som medel med insekticid och akaricid verkan. | |
FI51431C (fi) | Pysyvä, raa'an 1,2-bentsisotiatsolin-3-onin amiinisuolojen vesiliuos. | |
ES2151511T3 (es) | Derivado de tiazolina. | |
DK230580A (da) | Sisomicinderivater fremgangsmaade til fremstilling heraf samt deres anvendelse som laegemiddel | |
DK314483D0 (da) | Peenem-derivater, fremgangsmade til fremstilling deraf samt deres anvendelse som laegemidler | |
ES2037758T3 (es) | Un metodo de uso de un derivado quinolincarboxilico y su procedimiento de preparacion. | |
ES2157498T3 (es) | Derivados de triazol o sus sales. | |
AR245709A1 (es) | Procedimiento para la preparacion de derivados de urea y de carbamato. | |
PT82071B (pt) | Processo para a preparacao de derivados de homocisteina tiolactona | |
MX9203068A (es) | Compuestos activirales oralmente activos. | |
DK71586A (da) | 5-chlor-1,3,4-thiadiazol-2-yloxy-acetamider, deres fremstilling og anvendelse som herbicider | |
BR0013085A (pt) | Compostos espiro heterocìclicos como pesticidas | |
ES2117057T3 (es) | Compuesto heterociclico y cardiotonico que lo contiene como ingrediente activo. | |
ES2084742T3 (es) | Benzoxazinas herbicidamente activas. | |
BE816076A (en) | N-cyclohexyl-N'-substd-phenyl-benzamides - having anti-inflammatory and analgesic activity with low toxicity | |
ATE47841T1 (de) | 5-sulfonamido-1-aryl-pyrazole. | |
GB1113783A (en) | Improvements in or relating to esters of 4-alkyl-2,6-dinitrophenols and pesticides containing them | |
FR2237631A1 (en) | Ethyl benzthiazole-2-carbamates - for use as anthelmintics in man and animals |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
MM | Annulment or lapse due to non-payment of fees |